The Marine Biotechnology research group is currently ongoing active research in different fields of microalgal biotechnology, as well as in the exploitation of different marine organisms as sources of novel bioactive compounds.
OC2 objective is to provide well-anchored basic and integrated knowledge of the present-day oceanic processes at the regional scale, as well as to investigate their response to past global warm climate conditions.
Development of heterocyclic compounds applicable in medicine, environmental remediation or aquaculture. Investigation of structure, reactivity and activity of compounds obtained from synthesis or natural sources.
The main aim of the group is study the role of hormones and their metabolites on physiology and the evolution of the endocrine system, using fish as the principal model together with other key invertebrate and vertebrate models.
Molecular determinants and regulatory mechanisms (transcription and post transcription regulation, alternative and trans-splicing events, RNA editing, epigenetics) affecting gene expression during onset of skeletogenesis and maintenance of bone and cartilage integrity throughout life.
The overall research strategy of FBP is driven primarily by the need to translate strong basic science into clinically relevant advances and promoting transfer of technology, based on the integration of high quality multi-disciplinary academic, researcher and clinical activity with a strong focus on translational research.
We conduct research on ethology and welfare of aquatic animals. Other activities include developing an open-access database on the welfare of farmed fish, providing consultancy services for fish farms and organizing training actions at scientific and industry levels.